JADENU® SUBSTITUTING EXJADE® IN IRON OVERLOADED Β- THALASSEMIA MAJOR (BTM) PATIENTS: A PRELIMINARY REPORT OF THE EFFECTS ON THE TOLERABILITY, SERUM FERRITIN LEVEL, LIVER IRON CONCENTRATION AND BIOCHEMICAL PROFILES

JADENU® SUBSTITUTING EXJADE® IN IRON OVERLOADED Β- THALASSEMIA MAJOR (BTM) PATIENTS: A PRELIMINARY REPORT OF THE EFFECTS ON THE TOLERABILITY, SERUM FERRITIN LEVEL, LIVER IRON CONCENTRATION AND BIOCHEMICAL PROFILES

Abstract. Introduction: Due to the chronic nature of chelation therapy and the adverse consequences of iron overload, patient adherence to therapy is an important issue. Jadenu ® is a new oral formulation of deferasirox (Exjade ®) tablets for oral suspension. While Exjade®  is a dispersible tablet t...

Full description

Bibliographic Details
Main Author: Vincenzo De Sanctis
Format: Article
Language:English
Published: PAGEPress Publications 2018-10-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Thalassemia major
chelation therapy
deferasirox
liver iron concentration
serum ferritin
patient's satisfaction
adverse events.
Online Access:https://www.mjhid.org/index.php/mjhid/article/view/3640

Internet

https://www.mjhid.org/index.php/mjhid/article/view/3640

Similar Items